Newgen Software Technologies’ board approved the unaudited standalone and consolidated financial results for Q2 2025, ending September 30, 2025. The board also approved the issuance and allotment of equity shares under its ESOP 2022 and ESOP 2014 schemes. A total of 6,39,000 equity shares were allotted, increasing the company’s paid-up share capital to ₹1,42,31,77,870.
Financial Results Approval
Newgen Software Technologies announced the board’s approval of the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2025. This decision was made during a board meeting held on October 28, 2025.
Equity Share Allotment Under ESOP Schemes
The board also approved the issuance and allotment of equity shares under the company’s ESOP 2022 and ESOP 2014 schemes. The details of the allotment are as follows:
ESOP Scheme 2022
5,39,000 equity shares, each with a face value of ₹10, were allotted to the Newgen ESOP Trust. These shares rank equally with the existing equity shares of the company.
ESOP Scheme 2014
1,00,000 equity shares, each with a face value of ₹10, were allotted to the Newgen ESOP Trust. These shares also rank equally with the existing equity shares of the company.
Impact on Share Capital
Following the allotment of these shares, the company’s paid-up share capital has increased from ₹1,41,67,87,870 to ₹1,42,31,77,870.
Financial Performance Highlights (Consolidated)
Key consolidated financial figures for the quarter ended September 30, 2025, include:
- Revenue from operations: ₹40,079.35 lakhs
- Total Income: ₹41,401.65 lakhs
- Net profit for the period: ₹8,174.24 lakhs
Segment-Wise Revenue (Consolidated)
- India: ₹11,782.94 lakhs
- EMEA: ₹12,453.30 lakhs
- APAC: ₹6,345.01 lakhs
- USA: ₹9,498.10 lakhs
Source: BSE
